Trade Medtronic - MDT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.18 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.024068% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.001846% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Medtronic PLC ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 77.43 |
Open* | 77.32 |
1-Year Change* | -27.12% |
Day's Range* | 77.32 - 79.4 |
52 wk Range | 75.77-114.31 |
Average Volume (10 days) | 6.59M |
Average Volume (3 months) | 128.91M |
Market Cap | 105.60B |
P/E Ratio | 26.09 |
Shares Outstanding | 1.33B |
Revenue | 30.77B |
EPS | 3.04 |
Dividend (Yield %) | 3.42699 |
Beta | 0.73 |
Next Earnings Date | May 25, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 24, 2023 | 79.29 | 2.00 | 2.59% | 77.29 | 79.45 | 76.93 |
Mar 23, 2023 | 77.43 | -1.80 | -2.27% | 79.23 | 79.65 | 77.20 |
Mar 22, 2023 | 79.81 | -0.93 | -1.15% | 80.74 | 81.90 | 79.81 |
Mar 21, 2023 | 81.13 | 1.23 | 1.54% | 79.90 | 81.33 | 79.43 |
Mar 20, 2023 | 79.49 | 0.90 | 1.15% | 78.59 | 79.70 | 78.25 |
Mar 17, 2023 | 78.12 | -1.09 | -1.38% | 79.21 | 79.29 | 77.72 |
Mar 16, 2023 | 79.20 | 2.02 | 2.62% | 77.18 | 79.33 | 77.04 |
Mar 15, 2023 | 78.31 | 1.77 | 2.31% | 76.54 | 78.31 | 76.54 |
Mar 14, 2023 | 77.73 | -1.32 | -1.67% | 79.05 | 79.25 | 76.95 |
Mar 13, 2023 | 77.92 | 1.97 | 2.59% | 75.95 | 78.41 | 75.93 |
Mar 10, 2023 | 76.62 | -1.10 | -1.42% | 77.72 | 78.02 | 76.02 |
Mar 9, 2023 | 77.90 | -0.41 | -0.52% | 78.31 | 79.25 | 77.88 |
Mar 8, 2023 | 78.30 | -1.16 | -1.46% | 79.46 | 79.51 | 77.93 |
Mar 7, 2023 | 79.71 | -2.23 | -2.72% | 81.94 | 82.00 | 79.38 |
Mar 6, 2023 | 81.83 | -1.49 | -1.79% | 83.32 | 83.74 | 81.34 |
Mar 3, 2023 | 83.33 | 1.28 | 1.56% | 82.05 | 83.52 | 82.05 |
Mar 2, 2023 | 82.13 | 0.75 | 0.92% | 81.38 | 82.49 | 81.07 |
Mar 1, 2023 | 81.96 | -0.03 | -0.04% | 81.99 | 82.45 | 81.56 |
Feb 28, 2023 | 82.70 | -0.43 | -0.52% | 83.13 | 83.61 | 82.45 |
Feb 27, 2023 | 83.27 | 0.07 | 0.08% | 83.20 | 84.04 | 82.97 |
Medtronic Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 31686 | 30117 | 28913 | 30557 | 29953 |
Revenue | 31686 | 30117 | 28913 | 30557 | 29953 |
Cost of Revenue, Total | 9971 | 10355 | 9269 | 9064 | 9039 |
Gross Profit | 21715 | 19762 | 19644 | 21493 | 20914 |
Total Operating Expense | 25934 | 25941 | 24535 | 24774 | 23351 |
Selling/General/Admin. Expenses, Total | 10135 | 9776 | 9875 | 10232 | 9953 |
Research & Development | 2746 | 2493 | 2331 | 2330 | 2256 |
Depreciation / Amortization | 1733 | 1783 | 1756 | 1764 | 1823 |
Interest Expense (Income) - Net Operating | -117 | -224 | 226 | ||
Unusual Expense (Income) | 1154 | 1219 | 1303 | 1342 | -172 |
Other Operating Expenses, Total | 195 | 315 | 118 | 266 | 226 |
Operating Income | 5752 | 4176 | 4378 | 5783 | 6602 |
Interest Income (Expense), Net Non-Operating | -541 | -425 | -379 | -676 | -938 |
Other, Net | 306 | 144 | 56 | 90 | 11 |
Net Income Before Taxes | 5517 | 3895 | 4055 | 5197 | 5675 |
Net Income After Taxes | 5061 | 3524 | 4743 | 4662 | 5377 |
Minority Interest | -22 | -24 | -17 | -19 | 9 |
Net Income Before Extra. Items | 5039 | 3500 | 4726 | 4643 | 5386 |
Net Income | 5039 | 3606 | 4789 | 4631 | 3104 |
Income Available to Common Excl. Extra. Items | 5039 | 3500 | 4726 | 4643 | 5386 |
Income Available to Common Incl. Extra. Items | 5039 | 3606 | 4789 | 4631 | 3104 |
Diluted Net Income | 5039 | 3606 | 4789 | 4631 | 3104 |
Diluted Weighted Average Shares | 1351.4 | 1354 | 1351.1 | 1357.5 | 1368.2 |
Diluted EPS Excluding Extraordinary Items | 3.72873 | 2.58493 | 3.49789 | 3.42026 | 3.93656 |
Dividends per Share - Common Stock Primary Issue | 2.52 | 2.32 | 2.16 | 2 | 1.84 |
Diluted Normalized EPS | 4.58931 | 3.55835 | 4.13123 | 4.31147 | 3.82352 |
Total Extraordinary Items | 106 | 63 | -12 | -2282 | |
Total Adjustments to Net Income | 0 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Total revenue | 8089 | 7763 | 7847 | 7987 | 8188 |
Revenue | 8089 | 7763 | 7847 | 7987 | 8188 |
Cost of Revenue, Total | 2565 | 2433 | 2466 | 2507 | 2620 |
Gross Profit | 5524 | 5330 | 5381 | 5480 | 5568 |
Total Operating Expense | 6418 | 6104 | 6284 | 7128 | 6583 |
Selling/General/Admin. Expenses, Total | 2570 | 2521 | 2579 | 2510 | 2348 |
Research & Development | 652 | 668 | 676 | 750 | 632 |
Depreciation / Amortization | 435 | 432 | 431 | 436 | 446 |
Unusual Expense (Income) | 53 | 113 | 111 | 833 | 338 |
Other Operating Expenses, Total | 143 | -63 | 21 | 92 | 199 |
Operating Income | 1671 | 1659 | 1563 | 859 | 1605 |
Interest Income (Expense), Net Non-Operating | -167 | -103 | -86 | -51 | -94 |
Other, Net | 98 | 33 | 16 | 25 | 55 |
Net Income Before Taxes | 1602 | 1589 | 1493 | 833 | 1566 |
Net Income After Taxes | 1492 | 1483 | 1317 | 769 | 1366 |
Minority Interest | -6 | -4 | -6 | -6 | -6 |
Net Income Before Extra. Items | 1486 | 1479 | 1311 | 763 | 1360 |
Net Income | 1486 | 1479 | 1311 | 763 | 1360 |
Income Available to Common Excl. Extra. Items | 1485 | 1480 | 1311 | 763 | 1360 |
Income Available to Common Incl. Extra. Items | 1485 | 1480 | 1311 | 763 | 1360 |
Diluted Net Income | 1485 | 1480 | 1311 | 763 | 1360 |
Diluted Weighted Average Shares | 1343.9 | 1350.3 | 1355.3 | 1344.5 | 1357.9 |
Diluted EPS Excluding Extraordinary Items | 1.10499 | 1.09605 | 0.96731 | 0.5675 | 1.00155 |
Dividends per Share - Common Stock Primary Issue | 0.63 | 0.63 | 0.63 | 0.63 | 0.58 |
Diluted Normalized EPS | 1.05737 | 1.11753 | 1.06914 | 1.32317 | 1.38596 |
Total Adjustments to Net Income | -1 | 1 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 23059 | 22548 | 22031 | 21967 | 22980 |
Cash and Short Term Investments | 10573 | 10817 | 10948 | 9848 | 11227 |
Cash & Equivalents | 3714 | 3593 | 4140 | 4393 | 3669 |
Short Term Investments | 6859 | 7224 | 6808 | 5455 | 7558 |
Total Receivables, Net | 5551 | 5462 | 4645 | 6222 | 5987 |
Accounts Receivable - Trade, Net | 5551 | 5462 | 4645 | 6222 | 5987 |
Total Inventory | 4616 | 4313 | 4229 | 3753 | 3579 |
Other Current Assets, Total | 2319 | 1956 | 2209 | 2144 | 2187 |
Total Assets | 90981 | 93083 | 90689 | 89694 | 91393 |
Property/Plant/Equipment, Total - Net | 6267 | 6219 | 5755 | 4675 | 4604 |
Property/Plant/Equipment, Total - Gross | 14219 | 13698 | 12571 | 10920 | 10259 |
Accumulated Depreciation, Total | -7952 | -7479 | -6816 | -6245 | -5655 |
Goodwill, Net | 40502 | 41961 | 39841 | 39959 | 39543 |
Intangibles, Net | 15595 | 17740 | 19063 | 20560 | 21723 |
Long Term Investments | 881 | 687 | 480 | 372 | 515 |
Other Long Term Assets, Total | 4677 | 3928 | 3519 | 2161 | 2028 |
Total Current Liabilities | 12394 | 8509 | 10366 | 8472 | 10084 |
Accounts Payable | 2276 | 2106 | 1996 | 1953 | 1628 |
Accrued Expenses | 5367 | 5681 | 4839 | 4885 | 5232 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3742 | 11 | 2776 | 838 | 2058 |
Other Current Liabilities, Total | 1009 | 711 | 755 | 796 | 1166 |
Total Liabilities | 38430 | 41655 | 39952 | 39603 | 40673 |
Total Long Term Debt | 20372 | 26378 | 22021 | 24486 | 23699 |
Long Term Debt | 20316 | 26316 | 21976 | 24476 | 23678 |
Capital Lease Obligations | 56 | 62 | 45 | 10 | 21 |
Deferred Income Tax | 884 | 1028 | 1174 | 1278 | 1423 |
Minority Interest | 171 | 174 | 135 | 121 | 102 |
Other Liabilities, Total | 4609 | 5566 | 6256 | 5246 | 5365 |
Total Equity | 52551 | 51428 | 50737 | 50091 | 50720 |
Common Stock | 0.13307 | 0.13454 | 0.13411 | 0.13407 | 0 |
Additional Paid-In Capital | 24566 | 26319 | 26165 | 26532 | 28127 |
Retained Earnings (Accumulated Deficit) | 30250 | 28594 | 28132 | 26270 | 24379 |
Unrealized Gain (Loss) | -209 | 92 | 0 | -45 | -194 |
Other Equity, Total | -2056.13 | -3577.13 | -3560.13 | -2666.13 | -1592 |
Total Liabilities & Shareholders’ Equity | 90981 | 93083 | 90689 | 89694 | 91393 |
Total Common Shares Outstanding | 1330.74 | 1345.4 | 1341.07 | 1340.7 | 1354.22 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Total Current Assets | 23059 | 23303 | 22731 | 22434 | 22548 |
Cash and Short Term Investments | 10573 | 11221 | 10669 | 10595 | 10817 |
Cash & Equivalents | 3714 | 3479 | 2900 | 3004 | 3593 |
Short Term Investments | 6859 | 7742 | 7769 | 7591 | 7224 |
Total Receivables, Net | 5551 | 5446 | 5493 | 5431 | 5462 |
Accounts Receivable - Trade, Net | 5551 | 5446 | 5493 | 5431 | 5462 |
Total Inventory | 4616 | 4514 | 4349 | 4288 | 4313 |
Other Current Assets, Total | 2319 | 2122 | 2220 | 2120 | 1956 |
Total Assets | 90981 | 91804 | 91756 | 91802 | 93083 |
Property/Plant/Equipment, Total - Net | 5413 | 5251 | 5188 | 5162 | 6219 |
Property/Plant/Equipment, Total - Gross | 13365 | 13074 | 12978 | 12808 | 12700 |
Accumulated Depreciation, Total | -7952 | -7823 | -7790 | -7646 | -7479 |
Goodwill, Net | 40502 | 41346 | 41612 | 41720 | 41961 |
Intangibles, Net | 15595 | 16078 | 16523 | 16890 | 17740 |
Long Term Investments | 881 | 827 | 781 | 692 | 687 |
Other Long Term Assets, Total | 5531 | 4999 | 4921 | 4904 | 3928 |
Total Current Liabilities | 12394 | 8927 | 7803 | 7764 | 8509 |
Accounts Payable | 2276 | 1985 | 1917 | 1864 | 2106 |
Accrued Expenses | 5672 | 5694 | 5403 | 5553 | 5681 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3742 | 865 | 16 | 6 | 11 |
Other Current Liabilities, Total | 704 | 383 | 467 | 341 | 711 |
Total Liabilities | 38430 | 39262 | 39765 | 40316 | 41655 |
Total Long Term Debt | 20372 | 24290 | 25607 | 25958 | 26378 |
Long Term Debt | 20316 | 24232 | 25548 | 25898 | 26316 |
Capital Lease Obligations | 56 | 58 | 59 | 60 | 62 |
Deferred Income Tax | 884 | 968 | 1024 | 1054 | 1028 |
Minority Interest | 171 | 171 | 168 | 178 | 174 |
Other Liabilities, Total | 4609 | 4906 | 5163 | 5362 | 5566 |
Total Equity | 52551 | 52542 | 51991 | 51486 | 51428 |
Common Stock | 0.13307 | 0.13426 | 0.13449 | 0.13447 | 0.13454 |
Additional Paid-In Capital | 24566 | 25814 | 26059 | 26184 | 26319 |
Retained Earnings (Accumulated Deficit) | 30250 | 29607 | 28974 | 28511 | 28594 |
Unrealized Gain (Loss) | -209 | -22 | 48 | 104 | 92 |
Other Equity, Total | -2056.13 | -2857.13 | -3090.13 | -3313.13 | -3577.13 |
Total Liabilities & Shareholders’ Equity | 90981 | 91804 | 91756 | 91802 | 93083 |
Total Common Shares Outstanding | 1330.74 | 1342.57 | 1344.86 | 1344.67 | 1345.4 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 5062 | 3630 | 4806 | 4650 | 3095 |
Cash From Operating Activities | 7347 | 6240 | 7234 | 7007 | 4684 |
Cash From Operating Activities | 2707 | 2702 | 2663 | 2659 | 2644 |
Deferred Taxes | -604 | -422 | -1315 | -304 | -919 |
Non-Cash Items | 1070 | 1031 | 1019 | 1082 | 37 |
Cash Taxes Paid | 996 | 1250 | 878 | 1558 | 2542 |
Cash Interest Paid | 540 | 582 | 643 | 973 | 1147 |
Changes in Working Capital | -888 | -701 | 61 | -1080 | -173 |
Cash From Investing Activities | -1659 | -2866 | -3203 | -774 | 5858 |
Capital Expenditures | -1368 | -1355 | -1213 | -1134 | -1068 |
Other Investing Cash Flow Items, Total | -291 | -1511 | -1990 | 360 | 6926 |
Cash From Financing Activities | -5336 | -4136 | -4198 | -5431 | -11954 |
Financing Cash Flow Items | 163 | -268 | -81 | 14 | -50 |
Total Cash Dividends Paid | -3383 | -3120 | -2894 | -2693 | -2494 |
Issuance (Retirement) of Stock, Net | -2115 | -178 | -664 | -1885 | -1768 |
Issuance (Retirement) of Debt, Net | -1 | -570 | -559 | -867 | -7642 |
Foreign Exchange Effects | -231 | 215 | -86 | -78 | 114 |
Net Change in Cash | 121 | -547 | -253 | 724 | -1298 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 5062 | 3570 | 2086 | 769 | 3630 |
Cash From Operating Activities | 7347 | 5289 | 3061 | 1292 | 6240 |
Cash From Operating Activities | 2707 | 2019 | 1347 | 671 | 2702 |
Deferred Taxes | -604 | -234 | -78 | -11 | -422 |
Non-Cash Items | 1070 | 943 | 888 | 715 | 1031 |
Cash Taxes Paid | 996 | 842 | 615 | 249 | 1250 |
Cash Interest Paid | 540 | 295 | 280 | 63 | 582 |
Changes in Working Capital | -888 | -1009 | -1182 | -852 | -701 |
Cash From Investing Activities | -1659 | -1930 | -1493 | -784 | -2866 |
Capital Expenditures | -1368 | -979 | -649 | -378 | -1355 |
Other Investing Cash Flow Items, Total | -291 | -951 | -844 | -406 | -1511 |
Cash From Financing Activities | -5336 | -3387 | -2210 | -1055 | -4136 |
Financing Cash Flow Items | 163 | -52 | -46 | -4 | -268 |
Total Cash Dividends Paid | -3383 | -2540 | -1693 | -846 | -3120 |
Issuance (Retirement) of Stock, Net | -2115 | -794 | -470 | -204 | -178 |
Issuance (Retirement) of Debt, Net | -1 | -1 | -1 | -1 | -570 |
Foreign Exchange Effects | -231 | -87 | -51 | -42 | 215 |
Net Change in Cash | 121 | -115 | -693 | -589 | -547 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.3573 | 124491788 | 1243126 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4559 | 72586912 | 3184703 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.512 | 60029051 | 1039338 | 2022-12-31 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 2.548 | 33898890 | 1194858 | 2022-12-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.2442 | 29857047 | -1240263 | 2022-12-31 | LOW |
Capital Research Global Investors | Investment Advisor | 2.1658 | 28814669 | 37199 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0461 | 27222300 | 423715 | 2022-12-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.2071 | 16059161 | 936343 | 2022-12-31 | LOW |
Managed Account Advisors LLC | Investment Advisor | 1.1558 | 15377670 | -3007005 | 2022-12-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.0919 | 14527410 | -214609 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0274 | 13668496 | 626225 | 2022-12-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.9969 | 13263284 | 1797223 | 2022-12-31 | LOW |
Sanders Capital, LLC | Investment Advisor | 0.9515 | 12658542 | -199168 | 2022-12-31 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.9013 | 11990457 | 545538 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.8866 | 11794893 | -258903 | 2022-12-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7999 | 10641725 | 2548341 | 2022-12-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.7763 | 10328189 | 1336047 | 2022-12-31 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 0.7543 | 10034945 | 194817 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7234 | 9624338 | -453649 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.7002 | 9315796 | 255281 | 2022-12-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com Group500K+
Traders
92K+
Active clients monthly
$53M+
Monthly investing volume
$30M+
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Medtronic Company profile
Medtronic (MDT) is a global medical device manufacturer, headquartered in Dublin. Established in 1949, Medtronic managed to grow into the world’s biggest provider of medical services and solutions through a number of acquisitions. The company has six principal departments that create devices and equipment for the treatment of chronic diseases. The company’s main business units focus on diabetes, cardiac diseases management, and surgical technologies. Medtronic trades on the New York Stock Exchange (NYSE) and is featured in the S&P100 Index. Download the Capital.com app to get regular updates on the Medtronic share price data.Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20 On Hatch
Hatch Street Lower
DUBLIN
DUBLIN
IE
Income Statement
- Annual
- Quarterly
News

GBP/EUR forecast: Will the pound rise against the euro in 2023?
The British pound has been moving sideways against the Euro, yet can it regain momentum? Read on for a GBP/EUR forecast.
16:27, 24 March 2023
Shiba Inu price prediction: Can the meme coin build on recent gains?
What’s next for the Shiba Inu meme coin after a sluggish 2022 so far? Read more…
12:51, 24 March 2023
Who are the biggest bitcoin mining companies?
Bitcoin mining is big business, but who are the biggest bitcoin mining companies?
12:06, 24 March 2023
USD/PKR forecast: Will Pakistan’s rupee continue to fall?
The rupee has rebounded against the dollar in recent months, will this trend continue?
11:49, 24 March 2023
Amazon stock forecast: Where next for AMZN amid massive layoffs?
Amazon has been making tens of thousands of its workers redundant. Does this affect the market’s baseline Amazon stock forecast?
10:46, 24 March 2023
Sweatcoin price prediction: What is Sweatcoin?
Can Sweatcoin run to the front of the crypto pack?
15:19, 23 March 2023
Who owns the most bitcoin?
Want to know who owns the most bitcoin? Learn more about the biggest bitcoin whales.
14:54, 23 March 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com